Pharma IPR USA 2019 is a conference dedicated to Intellectual Property (IP) in the pharmaceuticals Industry as the backbone to ensure development of new treatments and cures.
Topics
- Legal Perspective on Paragraph IV Proceedings
- Overview on Hatch-Waxman Act and Its Impact on Drug Development Process
- Interplay between Patent Law and Reproducibility
- FDA Drivers for ANDA Filing and Litigation
- Analysis of Emerging Doctrine of Equivalents (DOE) in ANDA Cases
- Industry Insights on Hatch-Waxman and Paragraph IV Litigations
- Induced Infringement - Permissibility and Inevitability
Who should Attend
Senior attendees from biopharma & pharmaceuticals industry as well as IP attorneys and counsels.
